Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant

Blood

Volumn 94, Issue 7, 1999, Pages 2523-2529

  Storb, Rainer ^a   Yu, Cong ^b   Zaucha, J Maciej ^b   Deeg, H Joachim ^b   Georges, George ^b   Kiem, Hans Peter ^b   Nash, Richard A ^b   McSweeney, Peter A ^b   Wagner, John L ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHIMERA; DOG; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0033214355     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.7.2523.419k18_2523_2529     Document Type: Article

References (41)

1. Storb R, Yu C, McSweeney P: Mixed chimerism after transplantation of allogeneic hematopoietic cells, in Thomas ED, Blume KG, Forman SJ (eds): Hematopoietic Cell Transplantation (ed 2). Boston, MA, Blackwell Science, 1999, p 287
2. Yu C, Seidel K, Nash RA, Deeg HJ, Sandmaier BM, Barsoukov A, Santos E, Storb R: Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 91:2581, 1998
3. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P. Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048, 1997
4. Storb R, Yu C, Barnett T, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, McSweeney P, Seidel K, Georges G, Zaucha JM: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given lymph node irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 94:1, 1999
5. Khan A, Tomita Y, Sykes M: Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 62:380, 1996
6. Tomita Y, Khan A, Sykes M: Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61:477, 1996
7. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 3:783, 1997
8. Lee LA, Sergio JJ, Sykes M: Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 61:125, 1996
9. Tomita Y, Sachs DH, Khan A, Sykes M: Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61:469, 1996
10. Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M: Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 66:96, 1998
11. Sandmaier BM, Yu C, Gooley T, Santos EB, Storb R: MHC-haploidentical canine hematopoietic stem cell allografts using nonmyeloablative therapy. Blood 92:264a, 1998 (suppl 1, abstr 1086)
12. Cobbold SP, Martin G, Qin S, Waldmann H: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164, 1986
13. Wulfing C, Davis MM: A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282:2266, 1998
14. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721, 1991
15. Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792, 1992
16. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321, 1994
17. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607, 1992
18. Elwood ET, Larsen CP, Cho HR, Corbascio M, Ritchie SC, Alexander DZ, Tucker-Burden C, Linsley PS, Aruffo A, Hollenbaugh D, Winn KJ, Pearson TC: Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 65:1422, 1998
19. Gribben JG, Guinan EC, Boussiotis VA, Ke XY, Linsley L, Sieff C, Gray GS, Freeman GJ, Nadler LM: Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool. Blood 87:4887, 1996
20. Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P: Blockade of multiple costimulatory receptors induces hyporesponsiveness: Inhibition of CD2 plus CD28 pathways. Transplantation 62:1011, 1996
21. Pearson TC, Alexander DZ, Corbascio M, Hendrix R, Ritchie SC, Linsley PS, Faherty D, Larsen CP: Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 63:1463, 1997
22. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94:8789, 1997
23. Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ, Larsen CP: CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 61:997, 1996
24. Li Y, Zheng XX, Li XC, Zand MS, Strom TB: Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 66:1387, 1998
25. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA: Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62:876, 1996
26. Wagner JL, Works JD, Storb R: DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing (brief communication). Tissue Antigens 52:397, 1998
27. Ladiges WC, Storb R, Graham T, Thomas ED: Experimental techniques used to study the immune system of dogs and other large animals, in Gay WI, Heavener JE (eds): Methods of Animal Experimentation. New York, NY, Academic, 1989, p 103
28. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58:701, 1994
29. Reichert WL, Stein JE, French B, Goodwin P, Varanasi U: Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. Carcinogenesis 13:1475, 1992
30. Raff RF, Deeg HJ, Farewell VT, DeRose S, Storb R: The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. Tissue Antigens 21:360, 1983
31. Weiner RS, Srinivas NR, Calore JD, Fadrowski CG, Shyu WC, Tay LK: A sensitive enzyme immunoassay for the quantitation of human CTLA4Ig fusion protein in mouse serum: Pharmacokinetic application to optimizing cell line selection. J Pharmaceut Biomed Anal 15:571, 1997
32. Woolfrey AE, Nash RA, Frangoul HA, McSweeney PA, Sanders JE, Ochs HD, Storb R: Non-myeloablative transplant regimen used for induction of multi-lineage allogeneic hematopoietic mixed donor-host chimerism in patients with T-cell immunodeficiency. Blood 92:520a, 1998 (suppl 1, abstr)
33. Bean MA, Graham T, Appelbaum FR, Deeg HJ, Schuening F, Sale GE, Leisenring W, Pepe M, Storb R: Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts: Tolerance vs. abrogation of sensitization to non-DLA antigens. Transplantation 61:334, 1996
34. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, Zhao G, Sykes M: Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187:2037, 1998
35. Allison JP, Krummel MF: The Yin and Yang of T cell costimulation. (Review). Science 270:932, 1995
36. Lee KM, Chuang E, Griffin M, Khattri R, Hong DK, Zhang WG, Straus D, Samelson LE, Thompson CB, Bluestone JA: Molecular basis of T cell inactivation by CTLA-4. Science 282:2263, 1998
37. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609, 1993
38. Kundig TM, Shahinian A, Kawai K, Mittrucker HW, Sebzda E, Bachmann MF, Mak TW, Ohashi PS: Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41, 1996
39. + T cells and defective antibody production in vivo. J Exp Med 179:809, 1994
40. Speiser DE, Bachmann MF, Shahinian A, Mak TW, Ohashi PS: Acute graft-versus-host disease without costimulation via CD28. Transplantation 63:1042, 1997
41. Yu X-Z, Martin PJ, Anasetti C: Role of CD28 in acute graft-versus-host disease. Blood 92:2963, 1998